Home NDC 25021-465 Octreotide Acetate
Product NDC 25021-465
11-digit product format 250210465
Labeler code 25021
Product ID 25021-465_5e508c59-4170-441a-a94a-70b0bf28b8e4
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name octreotide acetate
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS; SUBCUTANEOUS
Labeler Sagent Pharmaceuticals
Application ANDA090834
Marketing category ANDA
Marketing start 2023-06-15
Substance OCTREOTIDE ACETATE
Active strength 500 ug/mL
Pharmacologic classes Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A090834-001 OCTREOTIDE ACETATE (PRESERVATIVE FREE) OCTREOTIDE ACETATE EQ 0.05MG BASE/ML INJECTABLE / INJECTION AP 2013-11-12 A090834-002 OCTREOTIDE ACETATE (PRESERVATIVE FREE) OCTREOTIDE ACETATE EQ 0.1MG BASE/ML INJECTABLE / INJECTION AP 2013-11-12 A090834-003 OCTREOTIDE ACETATE (PRESERVATIVE FREE) OCTREOTIDE ACETATE EQ 0.5MG BASE/ML INJECTABLE / INJECTION AP 2013-11-12
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 A090834-001 OCTREOTIDE ACETATE (PRESERVATIVE FREE) EQ 0.05MG BASE/ML INJECTABLE / INJECTION AP 2013-11-12 a50c72e98297…2026-08-01 22:54:32 2026-06 A090834-002 OCTREOTIDE ACETATE (PRESERVATIVE FREE) EQ 0.1MG BASE/ML INJECTABLE / INJECTION AP 2013-11-12 a50c72e98297…2026-08-01 22:54:32 2026-06 A090834-003 OCTREOTIDE ACETATE (PRESERVATIVE FREE) EQ 0.5MG BASE/ML INJECTABLE / INJECTION AP 2013-11-12 a50c72e98297…
Observed Orange Book normalized TE history# DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 25021-465-01 Octreotide Acetate 10 in 1 CARTON INJECTION, SOLUTION 10 10 25021-465-01 Octreotide Acetate 1 mL in 1 VIAL INJECTION, SOLUTION 1 10
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 25021-465 OCTREOTIDE ACETATE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] 9 Current NDC, Legacy NDC, 2 package rows 20250221_7ce2fc1e-7520-4d04-be45-2baba32ca24a.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 25021-465-01 25021046501 10 VIAL in 1 CARTON (25021-465-01) / 1 mL in 1 VIAL 10 vial 2023-06-15 0000-00-00 No No Current